734 Endo (Mycophenolate Mofetil 250 mg)

Pill with imprint 734 Endo is Blue & Orange, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is supplied by Endo Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; bullous pemphigoid; organ transplant, rejection prophylaxis; autoimmune hepatitis; ulcerative colitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 734 Endo

Mycophenolate mofetil

Imprint:

734 Endo

Strength:

250 mg

Color:

Blue & Orange

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Selective immunosuppressants

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Endo Pharmaceuticals Inc.

Inactive Ingredients:

ammonia
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
potassium hydroxide
povidone
propylene glycol
shellac
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.